Immune Checkpoint PD‐1/PD‐L1: Is There Life Beyond Antibodies?Markella Konstantinidou, Alexander Dömlingꝉ, Tryfon Zarganes‐Tzitzikas et al.|Angewandte Chemie International Edition|2017Cited by 133
Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)Tryfon Zarganes‐Tzitzikas, Alexander Dömlingꝉ, Grzegorz Dubin et al.|Expert Opinion on Therapeutic Patents|2016Cited by 104
Der Immuncheckpoint PD‐1/PD‐L1: Gibt es Therapieoptionen jenseits der Antikörper?Markella Konstantinidou, Alexander Dömlingꝉ, Tryfon Zarganes‐Tzitzikas et al.|Angewandte Chemie|2017Cited by 4